Clinical Trial Update: ATI-045 Versus Placebo in Patients With Moderate-to-Severe Atopic Dermatitis [Phase 2]

View source ↗

Summary

Phase 2 trial update for ATI-045 in moderate-to-severe atopic dermatitis. The study is currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atopic Dermatitis

Drugs mentioned

• ATI-045

Snippet

Sponsor: Aclaris Therapeutics, Inc. | Conditions: Atopic Dermatitis, Atopic | Phase 2 | Status: ACTIVE_NOT_RECRUITING